NEIBARIX Trademark

Trademark Overview


On Friday, February 9, 2024, a trademark application was filed for NEIBARIX with the United States Patent and Trademark Office. The USPTO has given the NEIBARIX trademark a serial number of 98399962. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 22, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The NEIBARIX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
neibarix

General Information


Serial Number98399962
Word MarkNEIBARIX
Filing DateFriday, February 9, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2024

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Friday, February 9, 2024NEW APPLICATION ENTERED
Sunday, June 9, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 24, 2024ASSIGNED TO EXAMINER
Wednesday, September 4, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, September 4, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 4, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 4, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, September 4, 2024SUSPENSION LETTER WRITTEN
Wednesday, September 4, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, September 4, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 12, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, September 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 2, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 22, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords


neibarix human vaccines